Feasibility of Affibody-Based Bioorthogonal Chemistry-Mediated Radionuclide Pretargeting, Journal of Nuclear Medicine, vol.57, issue.3, pp.431-437, 2016. ,
DOI : 10.2967/jnumed.115.162248
URL : http://jnm.snmjournals.org/content/57/3/431.full.pdf
Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity, Proceedings of the National Academy of Sciences, vol.2, issue.3, pp.1802-1809, 2000. ,
DOI : 10.1056/NEJM199308123290703
Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial, Journal of Nuclear Medicine, vol.57, issue.10, pp.1505-1516, 2016. ,
DOI : 10.2967/jnumed.116.172221
URL : https://hal.archives-ouvertes.fr/inserm-01415668
Pretargeting of renal cell carcinoma: improved tumor targeting with a bivalent chelate, Cancer Res, vol.59, pp.4400-4405, 1999. ,
In vitro evaluation of DNA-DNA hybridization as a two-step approach in radioimmunotherapy of cancer, Cancer Res, vol.54, pp.3479-86, 1994. ,
Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti???Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group, Journal of Clinical Oncology, vol.24, issue.11, pp.1705-1716, 2006. ,
DOI : 10.1200/JCO.2005.04.4917
Therapeutic Immunoconjugates. Which Cytotoxic Payload: Chemotherapeutic Drug (ADC) or Radionuclide (ARC)? Current Cancer Ther Rev, pp.54-65, 2016. ,
Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma, Blood, vol.104, issue.1, pp.227-263, 2004. ,
DOI : 10.1182/blood-2003-09-3284
Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide, European Journal of Nuclear Medicine and Molecular Imaging, vol.14, issue.9, pp.2153-64, 2011. ,
DOI : 10.1158/1078-0432.CCR-07-2031
Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131 I-labeled bivalent hapten, J Nucl Med, vol.41, pp.480-487, 2000. ,
DOI : 10.1002/(sici)1097-0142(19971215)80:12+<2618::aid-cncr37>3.0.co;2-d
A Novel Bispecific, Trivalent Antibody Construct for Targeting Pancreatic Carcinoma, Cancer Research, vol.68, issue.12, pp.4819-4845, 2008. ,
DOI : 10.1158/0008-5472.CAN-08-0232
URL : http://cancerres.aacrjournals.org/content/canres/68/12/4819.full.pdf
Perspectives on oncologic imaging with radiolabeled antibodies, Cancer, vol.55, issue.S12, pp.2431-2436, 1997. ,
DOI : 10.1002/1097-0142(19940201)73:3+<896::AID-CNCR2820731322>3.0.CO;2-H
URL : http://onlinelibrary.wiley.com/doi/10.1002/(SICI)1097-0142(19971215)80:12+<2431::AID-CNCR15>3.0.CO;2-D/pdf
Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy, Journal of Clinical Oncology, vol.24, issue.5, pp.823-857, 2006. ,
DOI : 10.1200/JCO.2005.03.8471
Monoclonal antibodies as reversible equilibrium carriers of radiopharmaceuticals, International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, vol.13, issue.4, pp.383-91, 1986. ,
DOI : 10.1016/0883-2897(86)90015-2
Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake, J Nucl Med, vol.33, pp.2006-2019, 1992. ,
Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10- tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy, Cancer Res, vol.54, pp.5937-5983, 1994. ,
Zevalin: the first radioimmunotherapy approved for the treatment of lymphoma, Expert Review of Anticancer Therapy, vol.99, issue.4, pp.485-93, 2002. ,
DOI : 10.1182/blood.V99.12.4336
Problems associated with radioimmunodetection and possibilities for future solutions, J Biol Response Mod, vol.6, pp.235-62, 1987. ,
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease, Journal of Nuclear Medicine, vol.57, issue.2, pp.248-51, 2016. ,
DOI : 10.2967/jnumed.115.167361
Alpha-versus beta-emitting radionuclides for pretargeted radioimmunotherapy of CEA-expressing human colon cancer xenografts, J Nucl Med, 2017. ,
DOI : 10.2967/jnumed.116.187021
URL : http://europepmc.org/articles/pmc5450366?pdf=render
Investigations of avidin and biotin for imaging applications, J Nucl Med, vol.28, pp.1294-302, 1987. ,
Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors, Theranostics, vol.6, issue.1, pp.93-103, 2016. ,
DOI : 10.7150/thno.12766
Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry, Molecular Cancer Therapeutics, vol.16, issue.1, pp.124-157, 2017. ,
DOI : 10.1158/1535-7163.MCT-16-0503
URL : http://mct.aacrjournals.org/content/molcanther/16/1/124.full.pdf
Optimization of Radioimmunotherapy of Solid Tumors: Biological Impediments and Their Modulation, Clinical Cancer Research, vol.13, issue.5, pp.1374-82, 2007. ,
DOI : 10.1158/1078-0432.CCR-06-2436
URL : http://clincancerres.aacrjournals.org/content/clincanres/13/5/1374.full.pdf
Bivalent Hapten-Bearing Peptides Designed for Iodine-131 Pretargeted Radioimmunotherapy, Bioconjugate Chemistry, vol.8, issue.4, pp.526-559, 1997. ,
DOI : 10.1021/bc970083h
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/ streptavidin in patients with metastatic colon cancer, Clin Cancer Res, vol.6, pp.406-420, 2000. ,
Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft, J Nucl Med, vol.40, pp.198-204, 1999. ,
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131 I-labeled bivalent hapten in a phase I optimization clinical trial, J Nucl Med, vol.47, pp.247-55, 2006. ,
A pretargeting system for tumor PET imaging and radioimmunotherapy, Front Pharmacol, vol.6, p.54, 2015. ,
Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma, Cancer Res, vol.55, pp.5864-5871, 1995. ,
Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice, Cancer Res. Erratum Cancer Res, vol.5050, pp.3445-526115, 1990. ,
Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response, J Nucl Med, vol.34, pp.1662-71, 1993. ,
Tumor pretargeting in mice using 99m Tc-labeled morpholino, a DNA analog, J Nucl Med, vol.43, pp.384-91, 2002. ,
Non-covalent antibody-mediated drug delivery, Nuclear Medicine Communications, vol.15, issue.6, pp.483-91, 1994. ,
DOI : 10.1097/00006231-199406000-00014
PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status, Theranostics, vol.5, issue.12, pp.1388-401, 2015. ,
DOI : 10.7150/thno.13348
A Novel Method of 18F Radiolabeling for PET, Journal of Nuclear Medicine, vol.50, issue.6, pp.991-999, 2009. ,
DOI : 10.2967/jnumed.108.060418
Y-biotin in Glioma Patients: Phase I Study and Preliminary Therapeutic Results, Cancer Biotherapy & Radiopharmaceuticals, vol.16, issue.3, pp.227-262, 2001. ,
DOI : 10.1089/10849780152389410
Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer, J Nucl Med, vol.34, pp.1267-73, 1993. ,
Iodine-131 and indium-111 labelled avidin and streptavidin for pre-targetted immunoscintigraphy with biotinylated anti-tumour monoclonal antibody, Nuclear Medicine Communications, vol.9, issue.11, pp.931-972, 1988. ,
DOI : 10.1097/00006231-198811000-00010
Pretargeting of Carcinoembryonic Antigen-Expressing Cancers with a Trivalent Bispecific Fusion Protein Produced in Myeloma Cells, Clinical Cancer Research, vol.11, issue.19, pp.7122-7131, 2005. ,
DOI : 10.1158/1078-0432.CCR-1004-0020
Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting, Proceedings of the National Academy of Sciences, vol.50, issue.3_Supplement, pp.6841-6847, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-0420
In???Vivo Chemistry for Pretargeted Tumor Imaging in Live Mice, Angewandte Chemie International Edition, vol.34, issue.19, pp.3375-3383, 2010. ,
DOI : 10.1016/j.nucmedbio.2007.04.001
Diels-Alder Reaction for Tumor Pretargeting: In Vivo Chemistry Can Boost Tumor Radiation Dose Compared with Directly Labeled Antibody, Journal of Nuclear Medicine, vol.54, issue.11, pp.1989-95, 2013. ,
DOI : 10.2967/jnumed.113.123745
URL : http://jnm.snmjournals.org/content/54/11/1989.full.pdf
Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement, Journal of Nuclear Medicine, vol.53, issue.8, pp.1185-92, 2012. ,
DOI : 10.2967/jnumed.111.101865
URL : https://hal.archives-ouvertes.fr/hal-00932253
Pretargeted Immuno-Positron Emission Tomography Imaging of Carcinoembryonic Antigen-Expressing Tumors with a Bispecific Antibody and a 68Ga- and 18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts, Molecular Cancer Therapeutics, vol.9, issue.4, pp.1019-1046, 2010. ,
DOI : 10.1158/1535-7163.MCT-09-0862
Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results, British Journal of Cancer, vol.20, issue.4, pp.934-976, 2013. ,
DOI : 10.1200/JCO.2002.11.076
URL : http://www.nature.com/bjc/journal/v109/n4/pdf/bjc2013376a.pdf
Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.9, issue.Suppl 1, pp.1593-602, 2014. ,
DOI : 10.1089/cbr.2006.21.106
A universal pretargeting system for cancer detection and therapy using bispecific antibody, Cancer Res, vol.63, pp.354-63, 2003. ,
DOI : 10.2172/898305
URL : https://www.osti.gov/servlets/purl/898305
Improved therapy of non-Hodgkin's lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibody, Leukemia, vol.30, issue.6, pp.1064-1073, 2005. ,
DOI : 10.1007/s00259-002-1090-0
URL : http://www.nature.com/leu/journal/v19/n6/pdf/2403751a.pdf
A New Tri-Fab Bispecific Antibody for Pretargeting Trop-2-Expressing Epithelial Cancers, Journal of Nuclear Medicine, vol.53, issue.10, pp.1625-1657, 2012. ,
DOI : 10.2967/jnumed.112.104364
URL : http://jnm.snmjournals.org/content/53/10/1625.full.pdf
Bifunctional antibody: a binary radiopharmaceutical delivery system for imaging colorectal carcinoma, Cancer Res, vol.51, pp.6650-6655, 1991. ,
Antibody???drug conjugates for cancer therapy, The Lancet Oncology, vol.17, issue.6, pp.254-62, 2016. ,
DOI : 10.1016/S1470-2045(16)30030-4
First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers, Journal of Nuclear Medicine, vol.57, issue.5, pp.741-747, 2016. ,
DOI : 10.2967/jnumed.115.161034
URL : http://jnm.snmjournals.org/content/57/5/741.full.pdf
Diabody Pretargeting with Click Chemistry In Vivo, Journal of Nuclear Medicine, vol.56, issue.9, pp.1422-1430, 2015. ,
DOI : 10.2967/jnumed.115.159145
Pretargeting for imaging and therapy in oncological nuclear medicine, EJNMMI Radiopharmacy and Chemistry, vol.54, issue.1, p.6, 2017. ,
DOI : 10.2967/jnumed.112.115840
URL : https://hal.archives-ouvertes.fr/inserm-01819175
Neuroendocrine tumours: the role of imaging for diagnosis and therapy, Nature Reviews Endocrinology, vol.45, issue.2, pp.102-116, 2014. ,
DOI : 10.1007/s00259-013-2369-z
Pretargeting of Carcinoembryonic Antigen-Expressing Tumors with a Biologically Produced Bispecific Anticarcinoembryonic Antigen x Anti-Indium-Labeled Diethylenetriaminepentaacetic Acid Antibody, Clinical Cancer Research, vol.11, issue.19, pp.7130-7136, 2005. ,
DOI : 10.1158/1078-0432.CCR-1004-0006
<sup>89</sup>Zr-PET Radiochemistry in the Development and Application of Therapeutic Monoclonal Antibodies and Other Biologicals, Current Topics in Medicinal Chemistry, vol.13, issue.4, pp.446-57, 2013. ,
DOI : 10.2174/1568026611313040005
Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase, J Nucl Med, vol.36, pp.837-878, 1995. ,
, Clin Cancer Res, vol.710, issue.10, pp.3137-3183, 2004.
A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels-Alder Click Chemistry, Journal of Nuclear Medicine, vol.54, issue.8, pp.1389-96, 2013. ,
DOI : 10.2967/jnumed.112.115840